Rockefeller Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.5M | Buy |
104,165
+15,272
| +17% | +$2.14M | 0.03% | 543 |
|
|
2025
Q4 | $10.9M | Buy |
88,893
+22,559
| +34% | +$2.74M | 0.02% | 641 |
|
|
2025
Q3 | $7.36M | Sell |
66,334
-4,226
| -6% | -$480K | 0.01% | 716 |
|
|
2025
Q2 | $7.82M | Sell |
70,560
-13,803
| -16% | -$1.47M | 0.02% | 683 |
|
|
2025
Q1 | $9.45M | Buy |
84,363
+7,916
| +10% | +$817K | 0.02% | 583 |
|
|
2024
Q4 | $7.05M | Buy |
76,447
+1,348
| +2% | +$121K | 0.02% | 633 |
|
|
2024
Q3 | $6.29M | Sell |
75,099
-1,402
| -2% | -$107K | 0.02% | 648 |
|
|
2024
Q2 | $5.25M | Sell |
76,501
-21,165
| -22% | -$1.41M | 0.01% | 676 |
|
|
2024
Q1 | $7.15M | Buy |
97,666
+1,589
| +2% | +$122K | 0.02% | 591 |
|
|
2023
Q4 | $7.78M | Sell |
96,077
-16,763
| -15% | -$1.3M | 0.03% | 531 |
|
|
2023
Q3 | $8.46M | Buy |
112,840
+12,871
| +13% | +$990K | 0.03% | 466 |
|
|
2023
Q2 | $7.7M | Buy |
99,969
+1,221
| +1% | +$97.4K | 0.03% | 506 |
|
|
2023
Q1 | $8.19M | Sell |
98,748
-28,489
| -22% | -$2.36M | 0.04% | 463 |
|
|
2022
Q4 | $10.9M | Sell |
127,237
-70,345
| -36% | -$5.57M | 0.05% | 341 |
|
|
2022
Q3 | $12.2M | Buy |
197,582
+40,229
| +26% | +$2.54M | 0.06% | 306 |
|
|
2022
Q2 | $9.72M | Buy |
157,353
+6,063
| +4% | +$375K | 0.05% | 354 |
|
|
2022
Q1 | $8.99M | Buy |
151,290
+8,587
| +6% | +$549K | 0.04% | 394 |
|
|
2021
Q4 | $10.4M | Buy |
142,703
+4,480
| +3% | +$309K | 0.05% | 344 |
|
|
2021
Q3 | $9.65M | Buy |
138,223
+28,235
| +26% | +$1.98M | 0.05% | 322 |
|
|
2021
Q2 | $7.57M | Buy |
109,988
+66,789
| +155% | +$4.46M | 0.04% | 348 |
|
|
2021
Q1 | $2.79M | Buy |
43,199
+6,253
| +17% | +$403K | 0.02% | 503 |
|
|
2020
Q4 | $2.15M | Buy |
36,946
+1,123
| +3% | +$67.8K | 0.02% | 502 |
|
|
2020
Q3 | $2.26M | Buy |
35,823
+10,854
| +43% | +$753K | 0.02% | 391 |
|
|
2020
Q2 | $1.92M | Buy |
24,969
+1,183
| +5% | +$90.7K | 0.02% | 401 |
|
|
2020
Q1 | $1.78M | Buy |
23,786
+1,296
| +6% | +$89.6K | 0.02% | 357 |
|
|
2019
Q4 | $1.46M | Buy |
22,490
+10,915
| +94% | +$711K | 0.02% | 391 |
|
|
2019
Q3 | $733K | Sell |
11,575
-22,373
| -66% | -$1.46M | 0.01% | 438 |
|
|
2019
Q2 | $2.29M | Sell |
33,948
-1,894
| -5% | -$125K | 0.03% | 240 |
|
|
2019
Q1 | $2.33M | Sell |
35,842
-16,123
| -31% | -$1.07M | 0.03% | 236 |
|
|
2018
Q4 | $3.25M | Buy |
51,965
+42,385
| +442% | +$2.96M | 0.06% | 152 |
|
|
2018
Q3 | $740K | Sell |
9,580
-10,381
| -52% | -$784K | 0.01% | 237 |
|
|
2018
Q2 | $1.41M | Buy |
19,961
+2,147
| +12% | +$152K | 0.02% | 187 |
|
|
2018
Q1 | $1.34M | Buy |
+17,814
| New | +$1.42M | 0.02% | 195 |
|
Other funds holding GILD
VCM
VPM
Rockefeller Capital Management's GILD Position: Q1 2026 in Review
Rockefeller Capital Management increased its Gilead Sciences (GILD) stake by 17% in Q1 2026, buying an estimated $2.14M and bringing the position to 104,165 shares worth $14.5M. The position accounts for 0.03% of the portfolio, ranked #543.
Rockefeller Capital Management first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Rockefeller Capital Management held 104,165 shares of Gilead Sciences worth $14.5M as of Q1 2026.
- Rockefeller Capital Management bought 15,272 Gilead Sciences shares in Q1 2026, an estimated $2.14M.
- Gilead Sciences made up 0.03% of Rockefeller Capital Management's portfolio in Q1 2026, its #543 holding.
- Rockefeller Capital Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.